Day: March 22, 2023

Form 8.3 – [Devro plc – 21 03 2023] – (CGWL)

Written by Customer Service on March 22, 2023. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree DEVRO PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Credent Wealth Management announces 2 new merger deals

Written by Customer Service on March 22, 2023. Posted in Mergers And Acquisitions.

Advisors in Oklahoma City, Oklahoma, and River Falls, Wisconsin, capitalize on Credent’s unmatched partnership opportunityMike Pepin Mike Pepin of TruNorth Financial joined Credent Wealth Management as a partnerTracy Miller Tracy Miller of Miller Private Wealth joined Credent Wealth Management as a partnerAuburn, Ind., March 22, 2023 (GLOBE NEWSWIRE) — Credent Wealth Management announces Tracy Miller of Miller Private Wealth and Mike Pepin of TruNorth Financial as the newest partners to join the firm. With Miller and Pepin joining Credent, the firm expands its offerings to Oklahoma City, Oklahoma, and adds to an already successful office in River Falls, Wisconsin. Advisors like Miller and Pepin interested in capturing the wealth creation opportunity of a 5-9x valuation while providing the highest level of service, planning,...

Logiq Reports Progress with Major Corporate Initiatives, Sees Strong Outlook Ahead for 2023

Written by Customer Service on March 22, 2023. Posted in Mergers And Acquisitions.

NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX:LGIQ), a leading provider of digital consumer acquisition solutions, provided a shareholder update today on its progress with a number of major corporate initiatives. “We have been preparing to report our 2022 results along with a detailed corporate update,” stated Logiq CEO, Brent Suen. “However, given the disclosure of a number of positive events over the past week, including the Form 4 filing of my large purchase of shares, we would like to take this opportunity to address some of the investor questions we’ve been receiving lately. In all, the recent events have been very positive and our goals are well on track.”Ionic Share Purchase Agreement: Logiq received a $3 million investment from Ionic Venture under a $40 million share purchase agreement initiated in March...

Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

– Founding CEO, Axel Bolte, MSc, MBA, to retire; Douglas A. Treco, Ph.D., to succeed as CEO – – Matthew Winton, Ph.D., appointed COO – – Upcoming clinical and regulatory milestones remain on track with previous guidance – – Current cash, cash equivalents and short-term investments anticipated to fund cash flow requirement into the fourth quarter of 2024 – BOSTON, March 22, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical- stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today reported financial results for the full year ended December 31, 2022, and provided recent business highlights. The Company also today announced that founding chief executive officer (CEO),...

Company Announcement 1/2023

Written by Customer Service on March 22, 2023. Posted in Public Companies.

March 22, 2023 NORDIC SHIPHOLDING A/SCompany Announcement: 01/2023 Published via NASDAQ OMX on March 22, 20232022 Annual Report The decision has been taken to solvently liquidate the Company and the Group in December 2022 subsequent to disposal of the remaining vessels, Nordic Anne, Nordic Agnetha and Nordic Amy, to their new owners in February 2022, March 2022 and April 2022, respectively. The Group’s and the Company’s results are affected by the disposal of the remaining activities and the ongoing liquidation. Please refer to Interim Report H1 2022 announced on 24 August 2022 for the discussion on the prior activities of the Company. In H2 2022, the financial result was affected by administration costs and adjustments related to the prior activities of the Group. With the commitment and continual support from the majority shareholder...

Altamira Therapeutics’ SemaPhore Delivery Platform Shows Significant Synergis-tic Effects of ZBTB46 mRNA with PD1 Immunotherapy in Control of Tumor Growth in Animal Model

Written by Customer Service on March 22, 2023. Posted in Public Companies.

HAMILTON, BERMUDA, March 22, 2023 (GLOBE NEWSWIRE) —Preprint of results from animal study shows restriction of tumor growth in mice treated with ZBTB46 mRNA nanoparticles based on Altamira’s SemaPhore™ delivery technology Nanoparticle treatment combined with immune checkpoint inhibitor results in synergistic control of tumor growthAltamira Therapeutics (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing RNA-based therapeutics that address important unmet medical needs, today announced the release of animal data by a Washington University School of Medicine (St. Louis, MO) research group showing restriction of tumor growth with a novel mRNA therapeutic delivered in nanoparticles based on the Company’s SemaPhore™ delivery platform. Expression of the ZBTB46 gene...

Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

Written by Customer Service on March 22, 2023. Posted in Public Companies.

Patent provides intellectual property protection until December 2040 PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030 There are currently no FDA approved treatments for PH-HFpEF Levosimendan combines two MoAs that, for the first time, specifically target the symptoms PH-HFpEF patients suffer.CHAPEL HILL, N.C., March 22, 2023 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today that the Company has been issued a patent by the United States Patent and Trademark Office (USPTO) with claims covering the use of IV levosimendan in the treatment of pulmonary...

Pacific Western Bank Provides Further Update and Details on Financial Strength

Written by Customer Service on March 22, 2023. Posted in Public Companies.

LOS ANGELES, March 22, 2023 (GLOBE NEWSWIRE) — Pacific Western Bank (the “Bank”), the primary subsidiary of PacWest Bancorp (NASDAQ: PACW) (the “Company”), today issues the following update regarding its financial strength, including liquidity and deposits, as well as other recent developments. Financial information is unaudited. Consistent with its announcement on March 17, 2023, the Bank continues to benefit from solid liquidity and stabilized deposit balances, with over $11.4 billion in available cash as of March 20, 2023, which exceeds total uninsured deposits of $9.5 billion as of March 20, 2023. The Bank also continues to have a diversified deposit base that includes commercial, community banking, homeowners associations, retail, and venture customers. Selected deposit information is shown below. December 31, 2022 March...

Water Ways Signs Smart Irrigation and Fertigation Project in Canada With a Total Expected Value of CAD$850,000

Written by Customer Service on March 22, 2023. Posted in Public Companies.

Apple Orchard Apple OrchardNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 22, 2023 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) (“Water Ways” or the “Company“), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, is pleased to announce that its fully owned Canadian subsidiary, Heartnut Grove WWT Inc. (“HGWWT“), has signed an agreement to design and supply a complete smart irrigation and fertigation system for a recurring customer. Under the agreement, HGWWT will provide irrigation and fertigation system for an apple orchard project in Southern Ontario. The first stage of the project, with a total expected value of CAD$850,000, will use the latest...

Wearable Devices Announces 2022 Financial Results

Written by Customer Service on March 22, 2023. Posted in Earnings Releases And Operating Results.

YOKNE’AM ILLIT, Israel, March 22, 2023 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a growth company developing a wrist-worn neural interface technology for B2B and B2C customers, today announced its financial results for the year ended December 31, 2022. The Company continued its investment in research and development, production and business development activities and together with the expenses incurred from the Company’s initial public offering (“IPO”) in the U.S. in September of 2022, net loss increased to $(6,496,000), or $(0.53) per diluted share, for the year ended December 31, 2022, as compared to a net loss of $(2,614,000), or $(0.27) per diluted share, for the year ended December 31, 2021. Cash balance at December 31, 2022 was $10.4 million, compared to $1.3 million...

Day: March 22, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice